Week in Review: January 4–8

Lack of data, disclosures in biomedical literature; hominin interbreeding and immunity; predicting patient responses to the flu vax; fewer off-target effects for engineered Cas9 variant

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKICOMMONS, NICKLAS BILDHAUERJust one of 268 randomly selected biomedical research studies containing empirical data contained a complete protocol, according to an analysis published in PLOS Biology this week (January 4). Examining 441 total papers published between 2000 and 2014, all selected at random, researchers from the Stanford University School of Medicine and the National Cancer Institute also reported on a lack of conflict-of-interest and other disclosures, as well as of instructions for accessing authors’ full data.

“What was most surprising to me was the complete lack of data-sharing and protocol availability,” study coauthor John Ioannidis of Stanford told The Scientist. “That was worse than I would have predicted.”

“It is commendable of the authors to put this study together,” said Arthur Caplan of New York University who was not part of the work. “It’s unique and a useful baseline of transparency, conflict of interest, and reproducibility [in the biomedical literature].”

DANNEMANN ET AL./AJHGWe humans may have our Neanderthal and Denisovan ancestors to thank for some innate immune genes, according to two studies published in The American Journal of Human Genetics this week (January 7). Two independent groups have found genomic evidence to suggest that present-day people inherited versions of several toll-like receptors (TLRs) that recognize pathogens through the interbreeding of human ancestors with Neanderthals and Denisovans.

“At least partially, Neanderthals may have harbored already adaptive mutations, mutations that rendered them more resistant to infections,” said Lluis Quintana-Murci of the Pasteur Institute in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours